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Unlike H chain complementarity determining 
regions 1 and 2, which are entirely encoded 
by the VH gene segment, CDR-H3 is created 
de novo by the VDJ rearrangement process 
(1–3). Imprecision in joining these gene seg-
ments permits exonucleolytic loss as well as 
palindromic (P junction) gain of terminal VH, 
DH, and JH sequence. The terminal deoxy-
nucleotidyl transferase (TdT) catalyzed inser-
tion of N nucleotides at the sites of joining 
permits the inclusion of nongermline sequence 
into CDR-H3 (1, 2). Together, these mecha-
nisms create a CDR-H3 repertoire that ranges 
from   unmodifi  ed and intact germline-encoded 
  sequence to rearrangements where extensive 
nibbling and N addition no longer permit 
identifi  cation of the original DH. The exten-
sive range of diversity available to CDR-H3 
has functional consequences because its loca-
tion at the center of the antigen-binding site, as 
classically defi  ned, permits this interval to often 
play a signifi  cant role in antigen recognition 
and binding (4–6).
Flanked on both sides by 12-base spacer 
recombination signal sequences, each DH gives 
the developing B cell access to six reading 
frames (RFs) of distinctly diff  erent germline 
  sequence. In practice, from shark to mouse 
to human, sequences encoded by RF1 gener-
ated by deletion dominate the mature B cell 
repertoire (7, 8). RF1 is typically enriched for 
tyrosine and glycine codons. Together, these 
two neutral amino acids contribute  40% of 
the amino acids in the CDR-H3 loop (8, 9).
To test the role of germline RF1 se-
quence in determining CDR-H3 amino acid 
usage and to test whether a mouse starting 
with altered germline sequence could rec-
reate a wild-type CDR-H3 repertoire by 
somatic means, we replaced central codons 
for RF1-encoded tyrosine and glycine in 
DFL16.1, the most JH-distal DH, with codons 
for arginine, histidine, and asparagine and 
deleted the intervening DH. We found that 
B lineage cells in the bone marrow of these 
mice maintained their preference for RF1 
through the mature, recirculating IgM+IgD+ 
B cell stage of development. As a result, usage 
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Tyrosine and glycine constitute 40% of complementarity determining region 3 of the 
immunoglobulin heavy chain (CDR-H3), the center of the classic antigen-binding site. 
To assess the role of DH RF1-encoded tyrosine and glycine in regulating CDR-H3 content 
and potentially infl  uencing B cell function, we created mice limited to a single DH encoding 
asparagine, histidine, and arginines in RF1. Tyrosine and glycine content in CDR-H3 was 
halved. Bone marrow and spleen mature B cell and peritoneal cavity B-1 cell numbers 
were also halved, whereas marginal zone B cell numbers increased. Serum immunoglobulin 
G subclass levels and antibody titers to T-dependent and T-independent antigens all 
  declined. Thus, violation of the conserved preference for tyrosine and glycine in DH RF1 
alters CDR-H3 content and impairs B cell development and antibody production.
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of arginine, asparagine, and histidine content in mature 
CDR-H3 loops tripled, whereas tyrosine and glycine con-
tent was reduced by one half.
This change in CDR-H3 amino acid content had 
functional consequences. Homozygous mutant mice ex-
hibited a consistent reduction in total B cell numbers, a 
redistribution of peripheral B cell subsets, and a decrease 
in total and antigen-  specifi  c antibody levels. These fi  nd-
ings confi  rm the power of the mechanisms used to regu-
late RF usage (7, 9, 10) and demonstrate a signifi  cant role 
for the DH gene segment in controlling CDR-H3 amino 
acid composition. They illustrate the importance of CDR-
H3 amino acid content in B cell development and anti-
body production.
RESULTS
Generation of the 𝖫D-iD mouse
We replaced the central portion of DFL16.1, the most 
VH-proximal DH (11), with the complete inverted coding 
  sequence of DSP2.2 (Fig. 1). This allowed us to replace 
central RF1 codons for tyrosine and glycine with those for 
arginine, histidine, and asparagine. We termed this hybrid 
DFL16.1-inverted DSP2.2 D element iD for inverted D. 
DFL16.1 sequence encoding tyrosine and serine at the 5′ 
and 3′ termini of the DH gene segment was retained to pre-
serve microhomology between the 3′ end of the DH and 
the 5′ end of JH (9, 10). iD RF1 generated by inversion 
(i-RF1) encompasses the original tyrosine enriched sequ-
ence of DSP2.2 RF1. iD RF2 and RF3 by deletion and 
Figure 1.  Generation of a single DH-containing IgH locus by use of 
the Cre-loxP system. (A) Illustration of the DH locus. Wild-type (WT), the 
locus after targeted replacement of DQ52 and DFL16.1 (iD), and the locus 
after Cre-mediated deletion leaving the single iD gene juxtaposed to the 
JH locus (∆D-iD) are shown. V and C denote the full set of germline vari-
able gene segments and constant region exons, respectively. (B) The se-
quence of iD. DSP2.2 has been embedded within DFL16.1 in an inverted 
orientation (in red). The average hydrophobicity is noted in parentheses. 
(C) Generation of the ∆D-iD allele. Southern blot analysis of tail DNA 
from wild-type (wt/wt), heterozygous iD (iD/wt), and heterozygous DH 
locus deleted iD (∆D-iD) mice. (D) The DH RF1 sequences of the wt and 
∆D-iD DH alleles. The mutant DH locus has lost the neutral, hydrophilic 
amino acids present at the center of the 13 WT DH gene segments, but 
has gained the positively charged amino acids present in iD. The interval 
corresponding to the region replaced by the inverted DSP 2.2 gene seg-
ment is outlined in yellow.JEM VOL. 203, June 12, 2006  1569
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RF1 and RF3 generated by inversion (i-RF2 and i-RF3) 
maintain a preference for hydrophobic amino acids, and 
RF3 and i-RF3 continue to incorporate termination  codons. 
We used gene targeting via homologous recombination in 
a BALB/c embryonic stem cell line (12) to create an IgH 
  allele (depleted DH locus with a single, mutated DFL16.1 gene 
segment containing inverted DSP 2.2 sequence [∆D-iD]) 
  limited to this single, modifi  ed DH.
Amino acid utilization in 𝖫D-iD/𝖫D-iD mature B cells 
refl  ects dominant use of iD RF1
We sorted bone marrow B lineage cells on the basis of surface 
expression of CD19, CD43, IgM, BP-1, and IgD (13, 14) 
(Fig. S1, available at http://www.jem.org/cgi/content/full/
jem.20052217/DC1), isolated total RNA, performed RT-
PCR using primers specifi  c for Cμ and the VH7183 family as 
representative of the repertoire as a whole, and performed 
detailed sequence analyses of the expressed repertoire as 
  described previously (12, 14).
We found no evidence of selection during development 
for use of DH RFs that lacked arginine, histidine, and asparagine. 
In fraction B CD19+CD43+BP-1−IgM− progenitor B cells, 
74% of the sequences used RF1 and, in fraction F 
CD19+CD43−IgM+IgD+ mature, recirculating B cells, 80% 
used the mutant RF1 (Fig. S2, available at http://www.jem.
org/cgi/content/full/jem.20052217/DC1). Although DH 
inversions were more frequent in ∆D-iD B cells than in the 
wild-type or depleted DH locus with single DFL16.1 gene 
segment (∆D-DFL) controls, their prevalence did not in-
crease with development even though iD i-RF1 recapitulates 
the normally preferred tyrosine-enriched sequence of DSP2.2 
RF1. Among the 326 iD-containing CDR-H3 sequences, 
four contained iD sequences in i-RF1 and seven used i-RF2 
(Tables S1 and S2, available at http://www.jem.org/cgi/
content/full/jem.20052217/DC1). The prevalence in frac-
tion B progenitor B cells of inverted sequences was equivalent 
to fraction F mature, recirculating B cells (4 out of 71 vs. 4 out 
of 76, respectively) (Fig. S2). Of 225 DFL16.1-containing 
sequences from the ∆D-DFL mice and the 902 wild-type 
  sequences containing an identifi  able  DH, none contained 
a DH inversion (P < 0.01 and P < 0.001, respectively).
We found no evidence of selection for sequences that 
had undergone extensive exonucleolytic loss at the termini 
of the iD gene segment (Fig. 2). The germline contribution 
of the iD gene segment remained virtually unchanged be-
tween fraction B progenitor B cells and fraction F mature, 
recirculating B cells with 95% of the CDR-H3 intervals 
containing identifi  able iD sequence in each. To control for 
the eff  ect of eliminating 12 out of the 13 DH gene segments 
in the DH locus, we compared this pattern of DH retention 
to that previously observed in ∆D-DFL mice, which are 
D-limited to a single DFL16.1 gene segment (12), and 
found it to be equivalent (P = 0.23). We did observe an 
increase in the contribution of 5′ terminal JH sequence with 
development, but this paralleled the pattern we had previ-
ously observed in WT mice (14).
Figure 2.  Deconstruction of CDR-H3 sequences containing the 
mutated iD DH gene segment during progressive stages in B cell 
development. (top) The potential contribution of the germline sequence 
of the VH gene segment, the iD DH gene segment, and the four JH gene 
segments to CDR-H3 length is illustrated. (bottom) The actual contribution 
of these components to 70 fraction B, 49 fraction C, 60 fraction D, 
76 fraction E, and 71 fraction F sequences. All components are shown 
to scale. N addition at the D→J junction decreases from fraction C to D 
(P < 0.02). JH sequence contribution increases from fraction B to E 
(P < 0.05). Other differences did not achieve statistical signifi  cance.1570  CHARGED CDR-H3 INTERVALS IMPAIR B CELL FUNCTION | Ippolito et al.
We found no evidence of selection for increased N nu-
cleotide content with development (Fig. 2). We did observe 
a decrease in the average number of N nucleotides inserted be-
tween D and J between fraction C CD19+CD43+BP- 1+IgM− 
early pre–B cells and fraction D CD19+CD43−IgM−IgD− late 
pre–B cells. However, this pattern contradicts the expe  cted
result if there was selection for N nucleotide–  encoded 
amino acids in response to surrogate light chain-associated 
  selection pressures.
The stability of exonucleolytic loss and N region gain cre-
ated CDR-H3 repertoires whose average length remained 
  unchanged during development (Fig. 2 and Fig. S3, available at 
http://www.jem.org/cgi/content/full/jem.20052217/DC1). 
The preservation of iD sequence contributed to a predomi-
nance of arginine, asparagine, and histidine at all stages of bone 
marrow repertoire development examined (Fig. 3 A). Together, 
these amino acids comprised approximately one third of the 
amino acids in the CDR-H3 loop, tripling their contribution 
to the repertoire when compared with controls (P < 0.001). 
Conversely, the contribution of tyrosine and glycine to the 
loop was halved (P < 0.001). Persistence of the charged amino 
acids was   associated with enrichment for CDR-H3 loops with 
Figure 3.  Amino acid usage and average hydrophobicity profi  les 
for CDR-H3 sequences containing the mutated iD DH gene segment 
during progressive stages in B cell development. (A) Distribution of 
individual amino acids in the CDR-H3 loop of sequences from homozy-
gous ∆D-iD, ∆D-DFL, and wild-type (WT) mice as a function of B cell 
development according to Hardy et al. (reference 13). The distributions are 
calculated through analysis of 9,322 individual amino acids from 342 
unique ∆D-iD CDR-H3 loops, 3,710 amino acids from 242 unique ∆D-DFL 
CDR-H3 loops, and 17,583 amino acids from 1,074 unique WT CDR-H3 
loops. (B) Distribution of average CDR-H3 hydrophobicities in V7183DJCμ 
transcripts from homozygous ∆D-iD mice in Hardy B-lineage bone mar-
row fractions B through F (reference 13). The normalized Kyte-Doolittle 
hydrophobicity scale (reference 49) has been used to calculate average 
hydrophobicity. Although this scale ranges from −1.3 to +1.7, only the 
range from −1.0 (charged) to +1.0 (hydrophobic) is shown. Prevalence is 
reported as the percent of the sequenced population of unique, in-frame, 
open transcripts from each B lineage fraction. To facilitate visualization 
of the change in variance of the distribution, the vertical lines mark the 
preferred range average hydrophobicity previously observed in WT frac-
tion F (reference 14). The number of unique V7183DJCμ sequences ana-
lyzed is shown for each developmental B cell subset. Among the ∆D-iD 
  sequences with loops, there are 172 sequences in fractions B, C, and D 
in the normal and charged range, and 10 sequences with an average 
 hydrophobicity  >0.600. There are 158 sequences in fractions E and F in 
the normal and highly charged range (≤0.700), but none in the highly 
hydrophobic range (≥0.700) (P < 0.01, χ2). The number of sequences in 
each fraction is shown. (C) Average hydrophobicity and standard error 
of mean of CDR-H3 intervals from VH 7183 DJCμ transcripts from homo-
zygous ∆D-iD, ∆D-DFL, and WT mice in Hardy B-lineage bone marrow 
  fractions B through F.JEM VOL. 203, June 12, 2006  1571
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an average normalized Kyte-Doolittle hydrophobicity value of 
less than −0.700 (Fig. 3 B and Table S3, available at http://
www.jem.org/cgi/content/full/jem.20052217/DC1).
Although highly charged CDR-H3 loops were retained 
in the mature ∆D-iD B cell repertoire, highly hydrophobic 
  sequences followed the normal pattern of loss during develop-
ment (P < 0.01) (Fig. 4 B and Table S4, available at http://
www.jem.org/cgi/content/full/jem.20052217/DC1) (12,14). 
The selective loss of these highly hydrophobic intervals in 
∆D-iD shifted the average hydrophobicity of the CDR-H3 
repertoire fi  rmly into the charged range (Fig. 4 C).
Use of VH7183 and JH gene segments is minimally affected 
by the change in CDR-H3 sequence
The global eff  ect of the shift in CDR-H3 hydrophobicity could 
have been ameliorated by a shift in VH or JH utilization, but we 
found no evidence that this had occurred either. As a popula-
tion, VH7183 usage in ∆D-iD B lineage cells proved highly 
similar to controls (Fig. 4). JH utilization in ∆D-iD during 
  development diff  ered from WT in that JH4 usage was dimin-
ished and JH1 usage was enhanced; however, this usage pattern 
matched that previously observed in ∆D-DFL (12, 14).
Forced use of a DH containing charged sequence impairs
B cell production
When compared with WT littermate controls, ∆D-iD mice 
exhibited a consistent reduction in total B cell numbers. The 
absolute numbers of CD19+ cells in the bone marrow, spleen, 
and peritoneal cavity of homozygous ∆D-iD BALB/c mice 
(Table I) were two thirds of that observed in WT littermate 
controls (P = 0.004, P < 0.0001, and P = 0.001, respectively). 
The ratio of Igκ- to Igλ-bearing cells in ∆D-iD B cells was 
similar to WT littermate controls (unpublished data).
Although total B cell numbers were decreased, some 
individual B cell subsets exhibited normal numbers and 
others demonstrated increases (Table I). The average 
  numbers of CD19+CD43+IgM−BP-1− fraction B cells, 
primarily pro–B cells, were higher than littermate controls 
(P = 0.05). The numbers of CD19+CD43+IgM−BP-1+ 
fraction C cells, primarily early pre–B cells, were essentially 
unchanged. When compared with wild-type littermate 
controls, the CD19+CD43−IgM−IgD− fraction D late 
pre–B cell and CD19+CD43−IgM+IgD− fraction E imma-
ture B cell subpopulations exhibited a 30% decrease in cell 
numbers (P = 0.008 and P = 0.05, respectively). This pattern 
of a progressive decrease in cell numbers with development 
in bone marrow was similar to that previously observed in 
∆D-DFL mice (Fig. 2) (12).
In the spleen, the absolute numbers of cells in 
the transitional T1 (CD19+AA4.1+IgMhiCD23−) and T2 
(CD19+AA4.1+IgMhiCD23+) subsets were similar to that in 
both WT and ∆D-DFL (Table I, and Fig. 5) (12, 14). How-
ever, when compared with controls, the absolute numbers of 
T3 (CD19+AA4.1+IgMloCD23+) and mature follicular (M) 
(CD19+CD23hiCD21lo) ∆D-iD B cells were reduced by one 
half (P = 0.002, P < 0.0001, and P < 0.0001, respectively), 
Figure 4.  VH 7183 and JH gene segment use during B cell develop-
ment. VH 7183 and JH use is reported as the percent of the sequenced 
population of unique, in-frame, open transcripts for Hardy fractions B (left) 
through F (right) according to the scheme of Hardy et al. (reference 13). 
Both VH and JH segments are arranged in germline order. The number of 
sequences analyzed is shown. (top) VH 7183 and JH use in homozygous 
∆D-iD mice (∆D-iD). (middle) VH 7183 and JH use in homozygous ∆D-DFL 
mice (∆D-DFL). (bottom) VH 7183 and JH use in wild-type, homozygous 
IgMa mice (WT). Signifi  cant differences between WT and ∆D-iD are 
  labeled with asterisks (**, P < 0.01, ***, P < 0.001 etc.; χ2).1572  CHARGED CDR-H3 INTERVALS IMPAIR B CELL FUNCTION | Ippolito et al.
whereas T3 and mature B cell numbers were indistinguishable 
from WT in ∆D-DFL. In marked contrast with the   decrease 
in the absolute numbers of mature follicular cells, the abso-
lute numbers of CD19+CD23loCD21hi marginal zone (MZ) 
B cells were increased by one third (P = 0.03) in ∆D-iD.
In the peritoneal cavity, the absolute numbers of B1a 
cells (CD19+CD5+Mac-1+) in ∆D-iD mice were one 
half (P < 0.0001) that of WT, and the B1b population 
(CD19+CD5−Mac-1+) was reduced by 25% (P = 0.06) 
  (Table I and Fig. 5). In contrast with the reduction in mature 
B cell numbers in the bone marrow and spleen, the numbers 
of peritoneal cavity B2 cells (CD19+CD5−Mac-1−) were 
slightly increased (P = 0.27) when compared with controls.
Humoral immune responses are impaired
We measured serum immunoglobulin levels in homozygous 
∆D-iD and WT littermates at 8 wk of age. The geometric 
mean concentration of all four IgG subclasses in the sera of 
∆D-iD mice was signifi  cantly less than that of WT (P = 0.02, 
P = 0.0004, P = 0.003, and P = 0.0002, respectively) 
(Fig. 6 A). The serum concentration of IgM and IgA was 
comparable to WT (P = 0.17 and P = 0.51, respectively).
Immune responses to both T-dependent and T-independent 
antigens were impaired. In WT BALB/c mice, intravenous 
challenge with DEX elicits a T-independent response that is 
dominated by λ1 light chain–bearing antibodies that express 
a diverse range of antigen-binding sites with heterogeneous 
CDR-H3 sequences (15, 16). The IgM and the Igλ anti-DEX 
responses in homozygous ∆D-iD BALB/c mice (Fig. 6 B) were 
signifi  cantly lower than those in WT (P < 0.01). In BALB/c, 
the primary response to the nitrophenylacetyl hapten of 
[4-hydroxy-3-nitrophenyl] acetyl-chicken γ globulin (NP19-
CGG) requires T cell help and contains a large fraction 
of IgG1λ anti-NP antibodies (17). After intraperitoneal 
  challenge, the anti-NP IgG response in ∆D-iD mice was 
threefold diminished when compared with WT littermates 
(P < 0.03) (Fig. 6 C). In BALB/c, immunization with puri-
fi  ed tetanus toxin (TT) elicits a T-dependent response that is 
dominated by κ light chain–bearing antibodies (18). After 
oral immunization with a recombinant strain of Salmonella 
that expresses the Tox C fragment of TT (19), the IgM anti-
TT response in ∆D-iD mice proved equivalent to WT litter-
mate controls, but the IgG response was approximately 
fourfold diminished (P = 0.0004) (Fig. 6 D). ELISA analysis 
using anti-κ and anti-λ reagents documented a preference for 
κ L chain–bearing antibodies in both the ∆D-iD and WT 
anti-TT response (unpublished data).
D  I  S  C  U  S  S  I  O  N 
Replacement of DH RF1-encoded tyrosine and glycine with 
codons for arginine, histidine, and asparagine resulted in 
  extensive substitution of the latter positively charged amino 
acids for the former neutral ones in the CDR-H3 repertoire. 
These fi  ndings document the power of the mechanisms used 
to regulate DH RF choice (7, 9, 10). Maintenance of the 
  terminal coding sequence of DFL16.1 (Fig. 1) preserved the 
ability to undergo microhomology-directed DHRF1→JH 
  recombination (9, 10). iD RF2 was placed in-frame with the 
upstream DFL16.1 ATG translation start site to permit Dμ 
protein production, which can invoke mechanisms of allelic 
exclusion (7, 9). The inclusion of termination codons in iD 
RF3 limited its usage. Rearrangement by deletion remained 
Table I.  Cell numbers in bone marrow and spleen of normal and mutant mice
Fraction
Bone marrow N ≥ Total cells x 106a CD19+ x 106 B x 105 C x 105 D x 105 E x 105 F x 105
WT 9 12.9 (0.3) 3.0 (0.2) 2.6 (0.3) 2.1 (0.3) 19.0 (1.4) 7.1 (0.4) 3.9 (0.5)
∆D-iD 12  11.6 (0.4)b  2.1 (0.2)d 4.3 (0.6)b 2.1 (0.3) 13.6 (1.2)c 4.9 (0.5)b 1.9 (0.3)d
Spleen Total cells x 106 CD19+ x 106 T1 x 105 T2 x 105 T3 x 105 MZ x 105 M x 105
WT 8 53.9 (3.3) 22.5 (1.0) 1.1 (0.1) 1.3 (0.1) 2.2 (0.1) 1.4 (0.1) 14.5 (1.4)
∆D-iD 10  42.3 (1.7)d 14.3 (0.6)e 1.2 (0.1) 1.2 (0.0) 1.2 (0.1)e 1.9 (0.2)b 7.8 (0.5)e
Peritoneal cavity Total cells x 105 CD19+ x 105 B1a x 105 B1b x 105 B2 x 105
WT 10 31.0 (3.2) 11.5 (0.7) 4.2 (0.4) 1.4 (0.2) 2.4 (0.3)
∆D-iD 10  23.7 (1.4)d 7.8 (0.6)e 1.9 (0.6)e 1.0 (0.1) 2.8 (0.3)
aTotal nucleated cells that excluded trypan blue. In the bone marrow, values shown are cell counts per femur (average cellularity of two femurs collected from each 
experimental animal) of paired 8-wk-old homozygous ∆D-iD (∆D-iD) or homozygous wild-type (WT) littermate progeny of heterozygous ∆D-iD/WT BALB/c mice. The standard 
error of the mean is shown in parentheses. The number of cells in fractions B (CD19+CD43+HSA+BP-1−), C (CD19+CD43+HSA+BP-1+), D (CD19+CD43−IgM−IgD−), 
E (CD19+CD43−IgM+IgD−), and F (CD19+CD43−IgMloIgDhi) was determined from the relative proportion of total cells. Cell counts per spleen of 8-wk-old homozygous ∆D-iD 
or wt littermate progeny of WT BALB/c mice. In the spleen, transitional T1 (CD19+AA4.1+sIgMhiCD23−), T2 (CD19+AA4.1+sIgMhiCD23+), and T3 (CD19+AA4.1+sIgMintCD23+) 
splenic B cell subsets were determined as described by Allman et al. (reference 46). Marginal zone (MZ, CD19+CD21hiCD23lo) and mature (M, CD19+CD21loCD23hi) B cell 
subsets were determined as described by Oliver et al. (reference 47). In the peritoneal cavity, values shown are average cell counts per single peritoneal lavage of 8-wk-old 
homozygous ∆D-iD or WT littermates. The number of B1a (CD19+CD5+), B1b (CD19+Mac-1+CD5−), and B2 (CD19+Mac-1−CD5−) cells were determined from the relative 
proportion of total cells.
bP ≤ 0.05.
cP ≤ 0.01.
dP ≤ 0.005.
eP ≤ 0.001 versus BALB/c wild-type littermates.JEM VOL. 203, June 12, 2006  1573
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favored over inversion. Together, these mechanisms main-
tained the preference for use of RF1 in spite of the change in 
the coding sequence of the mutant DH.
These mechanisms were not an absolute blockade for the 
generation of alternative CDR-H3 sequence. Inversions of 
iD that created WT tyrosine-enriched CDR-H3 sequence 
were observed. N nucleotides were introduced at random, 
and exonucleolytic nibbling did occur to the extent that 5% 
of the CDR-H3 sequences did not contain identifi  able iD 
sequence. As a result of the deletion of all but one DH gene 
segment, our model did not allow us to test whether selec-
tion for D-D fusions could have corrected the change in the 
sequence of the mutant DH. However, D-D fusion is a very 
rare event, and none of the 902 WT sequences with identifi  -
able DH contained a recognizable D-D fusion using our 
threshold of DH identifi  cation. This suggests that D-D fusion 
would be unlikely to contribute “ameliorated” sequences at a 
higher rate than that observed for iD inversion.
Because sequences with WT characteristics generated by 
iD inversion or by a combination of terminal sequence loss 
and N addition were detected in early B cell progenitors, 
  selection for these alternative sequences could have recreated 
a “WT” CDR-H3 repertoire in mature B cells. We had pre-
viously documented selection during development for a spe-
cifi  c range of CDR-H3 lengths, amino acid content, and 
average hydrophobicity in both WT (14) and ∆D-DFL mice 
(12), thus this seemed a likely outcome in ∆D-iD. However, 
∆D-iD RF1-encoded arginine, histidine, and asparagine 
CDR-H3 remained overrepresented at all stages of bone 
marrow B cell development examined, including the mature, 
recirculating CD19+IgM+IgD+ pool. Somatic selection 
did not shepherd the repertoire toward the WT range, even 
though the end result was a reduction in mature B cell num-
bers and antibody production. These data suggest that the 
  somatic mechanisms normally used to select the repertoire 
can be subordinate to evolutionary conservation of germline 
sequence in regulating CDR-H3 content even though B cell 
function may suff  er.
Early B cell development in the ∆D-iD mice followed a 
pattern similar to that observed in ∆D-DFL mice, which are 
limited to a single DH of normal, tyrosine- and glycine-
  enriched sequence (12). This pattern included an accumula-
tion of fraction B pro–B cells, normalization of the number 
of fraction C early pre–B cells, and a reduction in fraction D 
late pre–B and fraction E immature B cell numbers. The de-
creased effi     ciency with which developing ∆D-iD B cells 
transit through the bone marrow appears to refl  ect the loss of 
DH locus sequence rather than the change in the sequence of 
the remaining DH.
A potential mechanism that could have aff  ected early rep-
ertoire development is incomplete access or altered use of the 
full germline array of VH and JH gene segments. We chose 
VH7183 as the representative VH family because all of the 
family members encoded by the IgHa allele have been de-
fi  ned previously (20), key patterns of individual VH7183 gene 
segment utilization are well established (20–22), it accounts 
for a manageable 10% of the active repertoire (23), and 
VH7183 gene segments have been shown to contribute to 
both self- and nonself-reactivities (24, 25).
With a few limited exceptions, VH7183 gene segment 
use, including use of VH81X (7183.1), proved similar to WT 
controls at both early and late stages of development. VH 
  usage appeared minimally aff  ected by the central coding 
  sequence of DH or by the global alteration of CDR-H3 loop 
amino acid content.
Compared with WT, JH4 usage was depressed and the use 
of JH1 was enhanced. This pattern matched that previously 
observed among ∆D-DFL sequences, suggesting that the 
Figure 5.  Divergence in the absolute numbers of B lineage subpopu-
lations from the bone marrow, spleen, and peritoneal cavity of homo-
zygous ∆D-iD and ∆D-DFL mice relative to their littermate controls. 
Percent loss or gain in homozygous ∆D-iD and ∆D-DFL mice relative to WT 
littermate controls in the average absolute number of cells in bone marrow 
fractions B (CD19+CD43+HSA+BP-1−), C (CD19+CD43+HSA+BP-1+), D 
(CD19+CD43−IgM−IgD−), E (CD19+CD43−IgM+IgD−), and F (CD19+CD43−
IgMlo IgDhi); in splenic transitional T1 (CD19+AA4.1+sIgMhi-CD23−), T2 
(CD19+AA4.1+sIgMhiCD23+), T3 (CD19+AA4.1+sIgMloCD23+), marginal 
zone (MZ, CD19+CD21hiCD23lo), and mature (M, CD19+CD21loCD23hi) B cell 
subsets (references 46, 47); and in peritoneal cavity B1a (CD19+CD5+), B1b 
(CD19+CD5−Mac-1+), and B2 (CD19+CD5−Mac-1−) (Table I and Figs. S1–S4). 
The standard error of the mean of each B lineage subpopulation for 
the littermate controls averaged  11% of the absolute number of cells 
in each subpopulation (gray area). For ∆D-iD and ∆D-DFL, the standard 
error of the mean is shown as an error bar. *, P ≤ 0.05; **, P ≤ 0.01; 
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  alteration in JH usage was independent of the change in the 
coding sequence of the single, remaining DH (12). JH4 and, to 
a lesser extent, JH3 usage has been previously shown to be di-
minished in VDJ rearrangements from mice lacking DQ52 
together with cis-regulatory sequence immediately upstream 
of this JH-proximal gene segment (26). Together, these data 
suggest that the alteration in JH usage is the result of the dele-
tion of the remainder of the DH locus, perhaps, as previously 
suggested (26), as a result of a loss of the ability to engage in 
secondary D-J rearrangements.
Effi   cient transition from fraction B, primarily pro–B cells, 
to fraction C, early pre–B cells, is associated with successful 
creation of a functional H chain (13). Accumulation of pro–
B cells has been observed in the context of a deletion of 
DFL16.1 through JH1, inclusive, in C57BL/6 mice (27) and 
in the context of the ∆D-DFL deletion in BALB/c (12). 
Preliminary analysis of hybridomas obtained from ∆D-DFL 
BALB/c mice has shown that the nonfunctional ∆D-DFL 
allele is frequently found in a germline, unrearranged state 
(12). Ineffi   ciency in the initiation, progression, or comple-
tion of D→J rearrangement as a result of DH locus deletion 
may be the cause of the relative increase in the number of 
fraction B cells as well as in the alteration of JH usage.
Progression from fraction C, early pre–B cells, to fraction 
D, late pre–B cells, requires successful assembly of a pre–B 
cell receptor (28). Potential mechanisms for the decrease in 
the absolute number of cells in fraction D include an im-
paired ability to associate with surrogate light chain, as well as 
altered reactivity of the pre-BCR, including autoreactivity. 
Passage to fraction E, which contains immature B cells, then 
requires both in-frame light chain rearrangement and suc-
cessful association of the rearranged L chain with its H chain 
Figure 6.  Alterations in humoral immune function in homozygous 
∆D-iD mice. (A) The concentrations of IgM, IgG1, IgG2a, IgG2b, IgG3, and 
IgA in the serum of six 8-wk-old homozygous ∆D-iD and six homozygous 
WT littermates (ELISA). The geometric mean concentration of IgM (104 μg/ml 
[91–118, 95% confi  dence limits] and IgA (47 μg/ml [34–63]) proved 
comparable to WT (94 μg/ml [80–109], P = 0.17; and 38 μg/ml [23–64], 
P = 0.51, respectively). In contrast, the geometric mean concentrations of 
all four IgG subclasses were signifi  cantly reduced in the mutant mice. (IgG1 
201 μg/ml [122–329] vs. 382 μg/ml [267–543]; P = 0.02; IgG2a 141 μg/ml 
[81–245] vs. 516 μg/ml [333–799]; P = 0.0004; IgG2b 71 μg/ml [48–106] 
vs. 155 μg/ml [108–224], P = 0.003; and IgG3 82 μg/ml [52–130] vs. 224 
μg/ml [171–293]; P = 0.0002, respectively). (B) The primary T-  independent 
response to α-1,3 dextran (DEX) is diminished in homozygous ∆D-iD mice. 
The geometric mean concentrations of anti-DEX IgM and Igλ antibody 
titers 7 d after immunization were 10 μg/ml [4–23] vs. 79 μg/ml [43–143], 
and 11 μg/ml [2–63] vs. 83 μg/ml [51–134], respectively; P < 0.01). Titers in 
preimmune sera were <1 μg/ml; not depicted. (C) The primary T-dependent 
IgG response to NP19-CGG in homozygous. ∆D-iD mice is diminished when 
compared with WT littermates. **, P < 0.01; ***, P < 0.001. (D) TT-specifi  c 
antibody responses in ∆D-iD mice. 24 homozygous ∆D-iD and 24 WT 
  littermate controls were each orally immunized with 250 μl of 5 × 109 
  rSalmonella-ToxC. 4 wk later, plasma samples were collected and subjected 
to TT-specifi  c ELISA. The data are shown as the reciprocal log2 titer. For 
∆D-iD the mean IgM and IgG anti-TT titers were 9.1 ± 0.2 and 15.1 ± 0.5, 
respectively; whereas, for WT IgG the mean titer were 9.3.1 ± 0.2 and 
17.5 ± 0.3 (P = 0.64 and P = 0.0004, respectively).JEM VOL. 203, June 12, 2006  1575
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partner (13). Fraction E cells may lose surface IgM expression 
during receptor editing or may be released from the bone 
marrow to undergo maturation in the periphery, which is 
  associated with surface coexpression of IgD. Potential mech-
anisms for the decrease in the absolute numbers of cells in 
fraction E include failure to undergo proper L chain rear-
rangement, leading to (a) a block in the progression from D 
to E; (b) a more rapid progression from E to the transitional 
cell population in the periphery as a result of enhanced suc-
cess of H-L partnering; or, conversely, (c) enhanced receptor 
editing (29) as the result of functional failure of H-L partner-
ing, causing infl  ation in the numbers of cells identifi  ed as 
fraction D. This latter scenario seems less likely because frac-
tion D numbers were also depressed. Formal testing of these 
hypotheses will require kinetic evaluation of developing 
B cell populations in both ∆D-DFL and ∆D-iD mice (30).
Although the initial pattern of B lineage cell production 
in ∆D-iD proved similar to that observed in ∆D-DFL, a 
striking divergence in B cell numbers was observed among 
the splenic follicular and MZ populations, and among recir-
culating B cells in the bone marrow. The decrease in num-
bers in the ∆D-iD T3 transitional population paralleled the 
reduction in mature, follicular B cells. It has been hypothe-
sized that the antibody repertoires expressed by mature 
B cells in the follicles and MZ of the spleen are shaped by 
selection for antigen specifi  city (31), including negative se-
lection of B cells bearing autoreactive antibodies (32) and 
positive selection in both the recirculating mature B cell 
pool and the MZ (31, 33–35). Highly charged CDR-H3 se-
quences, especially long arginine-containing CDR-H3, are 
thought to be more likely to generate self-reactive anti-
bodies (36, 37); and preliminary studies indicate that IgG 
anti-DNA antibodies are more common in the sera of young 
∆D-iD mice than WT (unpublished data). It is possible that 
the increase in MZ cell numbers and the decrease in follicular 
and recirculating mature B cell numbers refl  ect a redirection 
of ∆D-iD B cells as a consequence of altered patterns of 
  autoreactivity. Analysis of the extent and quality of self-
  reactivity among ∆D-iD B cells is being actively pursued in 
our laboratory.
Although it remains unclear whether the T3 subset con-
sists of precursors to the mature, follicular compartment, 
these data would suggest that the cells in this compartment 
have suff  ered the same selective block as that experienced by 
splenic mature B cells. The sequence composition of immuno-
globulin CDR-H3 repertoires in the spleen is a current focus 
of investigation.
In the peritoneal cavity, the numbers of ∆D-iD B1a and 
B1b cells are reduced. This eff  ect is most pronounced for the 
B1a population, which is enriched for sequences derived 
from perinatal progenitors that tend to be more heavily infl  u-
enced by germline sequence as the result of diminished 
N addition (13). The ∆D-iD B2 population, which is derived 
from the same pool of conventional B cells that circulate 
through the blood and into the spleen and bone marrow (13), 
achieved slightly higher absolute numbers than WT. It is 
  unclear whether this represents a compensatory increase in 
numbers as a result of an increase in available physiologic 
space or whether the altered repertoire facilitates homing into 
the peritoneal cavity. Kinetic studies to address this question 
are currently ongoing in our laboratory.
A preference for tyrosine and glycine in the CDR-H3 
loop is common to jawed vertebrates (8). Tyrosine is 10-fold 
overrepresented in CDR-H3 repertoires when compared 
with protein sequence in general, and tyrosine and glycine 
typically provide approximately 4 out of every 10 amino ac-
ids in the CDR-H3 loop (38). Raaphorst et al. (39) have 
proposed that use of highly charged sequence in CDR-H3 
might reduce H chain stability. By extension, charged se-
quence could also have adversely aff  ected binding to surro-
gate light chain or L chain. Persistence of highly charged 
sequences through the mature B cell stage in the ∆D-iD mice 
described in this paper suggests that structural stability is 
  unlikely to be the primary force driving the preservation of 
tyrosine and glycine in CDR-H3.
Another hypothesis to explain preference for tyrosine and 
glycine in CDR-H3 is that repertoires enriched for these 
amino acids might facilitate achievement of optimal humoral 
immune responses to antigen (8, 40, 41). Although homozy-
gous ∆D-iD mice expressed normal serum concentrations of 
IgM and IgA, serum levels of all four IgG subclasses were re-
duced, indicating that the ability of homozygous ∆D-iD 
B cells to respond properly to a broad range of antigens might 
have been compromised. We tested this hypothesis by chal-
lenging the mice with DEX, a T cell–independent antigen, 
and with NP19-CGG (17, 42) and rSalmonella-Tox C (19, 43), 
both T cell–dependent antigens. After immunization, IgM 
titers to DEX and IgG titers to NP and TT were signifi  cantly 
lower than controls. Tyrosine and glycine in CDR-H3 may 
be required for production of effi   cient antigen-binding sites. 
Correlations between the change in CDR-H3 amino acid 
content to the antigen specifi  city or affi   nity of their host 
  immunoglobulin will require in vitro production of repre-
sentative antibodies followed by analysis of their structures 
and antigen-binding characteristics.
Our studies indicate that the sequence of DH RF1 estab-
lishes CDR-H3 amino acid usage. Somatic selection was not 
suffi   cient to recreate a “primary” repertoire enriched for ty-
rosine and glycine, even though B cell and antibody produc-
tion was impaired. We conclude that there are limits to the 
power of somatic selection of the expressed repertoire that 
require prior selection on a genomic or evolutionary scale. 
Thus, it might be said that the DH locus of “diversity” gene 
segments can also be considered a locus of “delimiting” ele-
ments, wherein the DH gene segment serves not only to 
  diversify but also to constrain the composition of CDR-H3 
into a range more likely to yield optimal immune function.
MATERIALS AND METHODS
Generation of targeted ES cells and the ∆D-iD mouse. The RI-2 
charon phage containing the BALB/c DFL16.1 locus was a gift from Y. 
Kurosawa (Fujita Health University, Toyoake, Japan) (7). An 800–base pair 
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mutagenesis. NotI and KpnI cloning sites were inserted 50 base pairs down-
stream of the 3′ recombination signal sequence and the central portion of 
DFL16.1 was replaced by inverted DSP2.2 sequence. Creation of the iD mu-
tant was confi  rmed by DNA sequencing. Additional germline sequence was 
added 5′ and 3′ of the modifi  ed BglII fragment, creating a targeting construct 
with a 4.2-kb 5′ long arm and a 0.7-kb 3′ short arm. A loxP-neo-loxP cassette 
was inserted into the NotI–KpnI cloning sites and an HSV-TK selection 
cassette was inserted into the tip of the long arm.
ESDQ52-KO, derived from WT BALB/c-I ES cells of the IgHa haplo-
type, had been targeted to insert a loxP site in lieu of a 240–base pair XhoI–
SacI fragment containing the DQ52 gene and a putative 5′ cis-regulatory 
element (26). Using standard protocols (44), this cell line was transfected 
with AscI-linearized iD targeting vector (pHWS48). One ES clone was 
identifi  ed by Southern blot analysis and DNA sequencing to contain the iD 
gene in cis with the DQ52-deleted mutation and was injected into C57BL/6J 
blastocysts. Two iD chimeric males were bred to yield BALB/cJ iD mice, 
and then bred to BALB/cJ hCMV-cre transgenic mice to delete the DH 
  locus. Integrity of the mutant allele was confi  rmed by Southern blot and 
DNA sequencing. Mice were maintained in a specifi  c pathogen-free barrier 
facility. All experiments with live mice were approved by and performed in 
compliance with IACUC regulations.
Flow cytometric analysis and cell sorting. Single cell suspensions were 
prepared from the marrow of two femurs by fl  ushing with staining buff  er 
(PBS with 2% FBS and 0.1% NaN3). Red blood cells were removed with 
RBC lysing solution (1 mM KHCO3, 0.15 M NH4Cl, and 0.1 mM 
Na2EDTA). Mononuclear cells were washed twice and resuspended in a 
master-mix of staining buff  er containing optimal concentrations of antibody 
reagents. Samples were analyzed on a FACSCalibur (Becton Dickinson).
A MoFlo instrument (DakoCytomation) was used for cell sorting. Cells 
from Hardy fractions C and D (45) were sorted from pooled bone marrow 
of two homozygous ∆D-iD and two WT sibling pairs (8 wk old) and then 
from two individual homozygous ∆D-iD mice (8–10 wk) and from two in-
dividual wt/wt mice (6–8 wk). B-lineage cells were enriched using anti-
CD19 magnetic beads and AutoMACS (Miltenyi Biotec). CD19+ cells were 
incubated on ice with the following: FITC-conjugated monoclonal anti-Igκ 
(187.1) and anti-Igλ (JC5-1), monoclonal PE-anti-CD43 (S7), biotinylated 
anti-BP-1 (developed secondarily with streptavidin (SA)-allophycocyanin), 
and Alexxa-594-anti-CD19 (1D3) (gifts from J.F. Kearney and R.P. Stephan, 
University of Alabama at Birmingham, Birmingham, AL). Cells within the 
lymphocyte gate, defi  ned by light scatter, were sorted as fraction C (Igκ/λ–, 
BP-1+, CD43+) or fraction D (Igκ/λ–, BP-1+, CD43–) lymphocytes. Cells 
from Hardy fractions E and F (13) were prepared individually from the bone 
marrow of three homozygous ∆D-iD or WT mice (10 wk old) derived from 
two litters and sorted in two independent experiments. Antibodies used 
were polyclonal FITC-anti-IgM (Southern Biotechnology Associates, Inc.), 
monoclonal PE–anti-IgD (11–26; Southern Biotechnology Associates, Inc.), 
and spectral red (SPRD) –anti-CD19 (Southern Biotechnology Associates, 
Inc.). Cells within the lymphocyte gate were sorted as fraction E (CD19+, 
IgM+, IgD–) and fraction F (CD19+, IgM+, IgDhigh) lymphocytes.
For quantitative studies of B cell development, we bred large num-
bers of heterozygous ∆D-iD mice and simultaneously compared cohorts 
of 8–12 female homozygous mutants of the same age to similarly sized 
cohorts of their WT littermates. FACS studies were performed over a 
3–4-d period. Bone marrow B cell subsets were characterized as de-
scribed in the previous paragraph (Fig. S1). In the spleen, transitional 
T1, T2, and T3 subsets were diff  erentiated by the surface expression of 
CD19, AA4.1, IgM, and CD23 (46) (Fig. S4, available at http://www.
jem.org/cgi/content/full/jem.20052217/DC1); and MZ and mature B 
cell populations were determined on the basis of surface expression of 
CD19, CD21 and CD23 (47) (Fig. S5, available at http://www.jem.
org/cgi/content/full/jem.20052217/DC1). In the peritoneal cavity; B1a, 
B1b, and B2 populations were identifi  ed on the basis of surface expression 
of CD19, CD5, and Mac-1 (13) (Fig. S6, available at http://www.jem.
org/cgi/content/full/jem.20052217/DC1).
Figs. S1–S4 give representative FACS profi  les for phenotypic diff  eren-
tiation of B lineage, bone marrow, spleen, and peritoneal cavity cells in 
  homozygous ∆D-iD and WT mice.
RNA, RT-PCR, cloning, and sequencing. Total RNA was prepared 
from 1–2 × 104 cells of each individual Hardy fraction, sorted directly into 
RLT lysing buff  er, using the QIAGEN RNeasy mini-kit. 30% of the total 
RNA preparation was used to synthesize fi  rst-strand cDNA that was primed 
with primer Cμ1 (5′-G  A  C  A  G  G  G  G  G  C  T  C  T  C  G  -3′) using AMV reverse 
transcriptase (Roche Molecular Biochemicals) at 42°C for 1 h. 15% of the 
cDNA was used to amplify V(D)JCμ joints using the QIAGEN Taq PCR 
Core Kit and the manufacturer’s recommended protocol under the follow-
ing conditions: 95°C denaturation for 2 min; 30 cycles of 94°C for 1 min, 
60°C for 1 min, and 72°C for 1 min; and a fi  nal 72°C extension for 10 min. 
The reaction buff  er contained 100 mM Tris-HCl, pH 8.8, 15 mM MgCl2, 
and 750 mM KCl. Primers used were AF303 (5′-G  G  G  G  C  T  C  G  A  G  G  A  G  T-
C  T  G  G  G  G  G  A  -3′), specifi  c for framework 1 of the VH7183 family (20), and 
the Cμ exon 1 primer Cμ2 (5′-C  A  G  G  A  T  C  C  G  A  G  G  G  G  G  A  A  G  A  C  A  T  T  T-
G  G  -3′). PCR products were cloned (TOPO-TA Cloning Kit; Invitrogen) 
and sequenced using the primer Cμ2 and Big Dye chemistry (ABI 377; 
  Applied Biosystems).
Immunizations. To determine basal levels of immunoglobulin isotypes in 
unimmunized 8-wk-old ∆D-iD and WT littermates, class-specifi  c unlabeled 
and alkaline-phosphatase (AP)–labeled antibodies were used (Southern 
  Biotechnology Associates, Inc.).
For the DEX response, homozygous ∆D-iD and WT littermates (9–12 
wk) were immunized intravenously with 100 μg of Dextran B-1355S in sa-
line (a gift from J.F. Kearney) and bled 7 d later. For the NP-CGG response 
(45), homozygous ∆D-iD and WT littermates (16 wk) were immunized 
  intraperitoneally with 10 μg of NP19-CGG (gift from T.I. Novobrantseva, 
Center for Blood Research, Boston, MA) precipitated in potassium alumi-
num sulfate (alum) in saline. Mice were bled from tail veins weekly.
Quantitative anti-DEX and anti-NP ELISA assays were performed 
  using DEX- and NP-BSA (gifts from J.F. Kearney) as antigens coated at 
25 μg/ml PBS onto CoStar EIA/RIA plates. Assays of IgM anti-DEX sera 
were performed as described previously using MOPC 104E as a standard 
(48). Assays of anti-NP sera were performed using class-specifi  c control 
monoclonal antibodies B1-8 and 17.2.25. After overnight 4°C incubation 
with serum samples and isotype-matched antibody standards, plates were 
blocked and incubated with AP-labeled goat anti–mouse IgM, IgG, or Igλ 
as required (Southern Biotechnology Associates, Inc.); plates were devel-
oped using p-nitrophenyl phosphate substrate (Sigma-Aldrich). For all 
ELISAs, twofold serial dilutions of individual serum samples were made 
in 1% BSA in PBS, and all ELISAs were read at 405 nm using a Benchmark 
microplate reader and software (Bio-Rad Laboratories).
To compare TT-specifi  c antibody responses between ∆D-iD and WT 
littermate controls, a recombinant Salmonella typhimurium BRD 847 (aroA−, 
aroD−) expressing the Tox C fragment of TT (rSalmonella-Tox C) was used 
(19). Cohorts of 24 mice were given a primary oral dose of 5 × 109 rSalmo-
nella-Tox C at day 0. Plasma samples were collected at day 28 for the analysis 
of TT-specifi   c IgG antibodies by ELISA. Falcon microtest assay plates 
(  Becton Dickinson) were coated with an optimal concentration of TT 
(100 μl of 5 μg/ml) in PBS overnight at 4°C. Twofold serial dilutions of 
samples were added after blocking with PBS containing 1% BSA. To detect 
antigen-  specifi   c antibody levels, horseradish peroxidase–conjugated, goat 
anti–mouse μ and γ heavy chain-specifi  c antibodies were used (Southern 
Biotechnology Associates, Inc.). In some experiments, goat anti–mouse κ or 
λ Abs were used as detection antibodies. Endpoint titers were expressed as 
the last dilution yielding an optical density at 414 nm (OD414) of >0.1 U 
above negative control values after 15 min incubation (19, 43).
Sequence analysis of CDR-H3. Gene segments were assigned according 
to published germline sequences for the IgH gene segments as listed in the 
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immunoglobulin heavy chain was defi  ned to include those residues located 
between the conserved cysteine (C92) of FR3 and the conserved tryptophan 
(W103) of FR4. Average hydrophobicity of CDR-H3 was calculated as 
  described previously (13). The sequences reported in this paper have been 
placed in the GenBank database (accession nos. AY205614-AY205988 and 
DQ226217-DQ226509).
Statistical analysis. Population means (fl  ow cytometry, sequence data, and 
ELISA) were analyzed using an unpaired, two-tailed Student’s t test for pop-
ulations that were normally distributed and with the nonparametric Mann-
Whitney for those that were not. Titers against antigen are reported as the 
geometric mean and 95% confi  dence intervals. Frequencies within a popula-
tion (sequence data) were analyzed using a two-tailed Fisher’s exact test. The 
overall frequencies of amino acids within groups of sequences were studied 
using a χ2 test with 19 degrees of freedom. For frequencies of individual 
amino acids, a χ2 test was performed. Analysis was performed with JMP IN 
version 5.1 (SAS Institute, Inc.). Means are accompanied by the standard 
  error of the mean.
Online supplemental material. Figs. S1 and S4–S6 illustrate represen-
tative fl  ow cytometric gates and analyses of bone marrow, spleen, and 
peritoneal B-lineage cells from homozygous ∆D-iD and WT littermates. 
Fig. S2 documents DH RF usage during B cell development. Fig. S3 pre-
sents the average length of CDR-H3 in VH7183DJCμ transcripts from 
homozygous ∆D-iD, ∆D-DFL, and WT mice in bone marrow B-lineage 
subsets. Table S1 lists the nucleotide sequences of CDR-H3 from homo-
zygous ∆D-iD mice that contain an inverted DH gene segment. Table S2 
presents the predicted amino acids sequences of CDR-H3 that contain an 
inverted DH gene segment. Table S3 presents the predicted amino acid se-
quences of CDR-H3 whose average Kyte-Doolittle hydrophobicity is less 
than −0.700. Table S4 presents the Predicted amino acid sequences of 
CDR-H3 with average Kyte-Doolittle hydrophobicity greater than 
+0.700. Also included in the supplemental material is an Excel spread-
sheet containing the deconstructed nucleotide sequences of the CDR-H3 
from homozygous ∆D-iD and littermate control bone marrow B-lineage 
cells. All online supplemental material is available at http://www.jem.
org/cgi/content/full/jem.20052217/DC1.
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